The DOI matches its Crossref record; 145 of the 145 references it cites were found in a registry or an index.
Telomerase and cancer
Abstract
Telomerase, a eukaryotic ribonucleoprotein (RNP) complex, contains both an essential RNA and a protein reverse transcriptase subunit. By reverse transcription, the telomerase RNP maintains telomere length stability in almost all cancer cells. Over the past few years there has been significant progress in identifying the components of the telomerase holoenzyme complex and the proteins that associate with telomeres, in order to elucidate mechanisms of telomere length regulation. This review covers recent advances in the field including the use of telomerase in cancer diagnostics and an overview of anti-telomerase cancer therapeutic approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091 · cited 3×
“Most human cancers have short telomeres and express high levels of telomerase, whereas in most normal somatic tissues telomerase is absent (35,36).”
BackgroundSelf-citationThe limited in vitro lifetime of human diploid cell strains
Hayflick, L. (1965) · Experimental Cell Research · doi:10.1016/0014-4827(65)90211-9 · Cited by 5,876
Extension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975
Self-citationIdentification of a specific telomere terminal transferase activity in tetrahymena extracts
Greider, C. W., & Blackburn, E. H. (1985) · Cell · doi:10.1016/0092-8674(85)90170-9 · Cited by 3,400
A survey of telomerase activity in human cancer
Shay, J. W., & Bacchetti, S. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00062-2 · Cited by 2,794 · cited 3×
“Most human cancers have short telomeres and express high levels of telomerase, whereas in most normal somatic tissues telomerase is absent (35,36).”
BackgroundSelf-citationMammalian Telomeres End in a Large Duplex Loop
Griffith, J. D., Comeau, L., Rosenfield, S., Stansel, R. M., Bianchi, A., Moss, H., & de Lange, T. (1999) · Cell · doi:10.1016/s0092-8674(00)80760-6 · Cited by 2,447
Creation of human tumour cells with defined genetic elements
Hahn, W. C., Counter, C. M., Lundberg, A. S., Beijersbergen, R. L., Brooks, M. W., & Weinberg, R. A. (1999) · Nature · doi:10.1038/22780 · Cited by 2,345
Telomerase Catalytic Subunit Homologs from Fission Yeast and Human
Nakamura, T. M., Morin, G. B., Chapman, K. B., Weinrich, S. L., Andrews, W. H., Lingner, J., Harley, C. B., & Cech, T. R. (1997) · Science · doi:10.1126/science.277.5328.955 · Cited by 2,256
The RNA Component of Human Telomerase
Feng, J., Funk, W. D., Wang, S.-S., Weinrich, S. L., Avilion, A. A., Chiu, C.-P., Adams, R. R., Chang, E., Allsopp, R. C., Yu, J., et al. (1995) · Science · doi:10.1126/science.7544491 · Cited by 2,227
Telomere length predicts replicative capacity of human fibroblasts.
Allsopp, R. C., Vaziri, H., Patterson, C., Goldstein, S., Younglai, E. V., Futcher, A. B., Greider, C. W., & Harley, C. B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10114 · Cited by 2,200
Counter, C. M., Avilion, A. A., LeFeuvre, C. E., Stewart, N. G., Greider, C. W., Harley, C. B., & Bacchetti, S. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05245.x · Cited by 2,096
The multistep nature of cancer
Vogelstein, B., & Kinzler, K. W. (1993) · Trends in Genetics · doi:10.1016/0168-9525(93)90209-z · Cited by 1,853
Olovnikov (1973) · doi:10.1016/0022-5193(73)90198-7 · Cited by 1,847
A highly conserved repetitive DNA sequence,(TTAGGG) n, present at the telomeres of human chromosomes
Moyzis, R. K., Buckingham, J. M., Cram, L. S., Dani, M., Deaven, L. L., Jones, M. D., Meyne, J., Ratliff, R. L., & Wu, J. R. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.18.6622 · Cited by 1,820
Rosenberg, S. A., Yang, J. C., Schwartzentruber, D. J., Hwu, P., Marincola, F. M., Topalian, S. L., Restifo, N. P., Dudley, M. E., Schwarz, S. L., Spiess, P. J., et al. (1998) · Nature Medicine · doi:10.1038/nm0398-321 · Cited by 1,784
TRF2 Protects Human Telomeres from End-to-End Fusions
van Steensel, B., Smogorzewska, A., & de Lange, T. (1998) · Cell · doi:10.1016/s0092-8674(00)80932-0 · Cited by 1,709
Telomere reduction in human colorectal carcinoma and with ageing
Hastie, N. D., Dempster, M., Dunlop, M. G., Thompson, A. M., Green, D. K., & Allshire, R. C. (1990) · Nature · doi:10.1038/346866a0 · Cited by 1,650
Morin, G. B. (1989) · Cell · doi:10.1016/0092-8674(89)90035-4 · Cited by 1,495
Telomere elongation in immortal human cells without detectable telomerase activity
Bryan, T. M., Englezou, A., Gupta, J., Bacchetti, S., & Reddel, R. R. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00098.x · Cited by 1,279 · cited 1×
“Thus, escape from cellular senescence and becoming immortal by activating telomerase, or an alternative mechanism to maintain telomeres (43), constitutes an additional step in oncogenesis that most tumors require for their ongoing proliferation.”
BackgroundReverse Transcriptase Motifs in the Catalytic Subunit of Telomerase
Lingner, J., Hughes, T. R., Shevchenko, A., Mann, M., Lundblad, V., & Cech, T. R. (1997) · Science · doi:10.1126/science.276.5312.561 · Cited by 1,269
Control of telomere length by the human telomeric protein TRF1
van Steensel, B., & de Lange, T. (1997) · Nature · doi:10.1038/385740a0 · Cited by 1,219
A telomerase component is defective in the human disease dyskeratosis congenita
Mitchell, J. R., Wood, E., & Collins, K. (1999) · Nature · doi:10.1038/990141 · Cited by 1,168
Greider, C. W., & Blackburn, E. H. (1987) · Cell · doi:10.1016/0092-8674(87)90576-9 · Cited by 1,150
Telomere loss: mitotic clock or genetic time bomb?
Harley, C. B. (1991) · Mutation Research/DNAging · doi:10.1016/0921-8734(91)90018-7 · Cited by 1,139
Inhibition of telomerase limits the growth of human cancer cells
Hahn, W. C., Stewart, S. A., Brooks, M. W., York, S. G., Eaton, E., Kurachi, A., Beijersbergen, R. L., Knoll, J. H. M., Meyerson, M., & Weinberg, R. A. (1999) · Nature Medicine · doi:10.1038/13495 · Cited by 1,030
Greider, C. W. (1996) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.65.070196.002005 · Cited by 1,021
Tankyrase, a Poly(ADP-Ribose) Polymerase at Human Telomeres
Smith, S., Giriat, I., Schmitt, A., & de Lange, T. (1998) · Science · doi:10.1126/science.282.5393.1484 · Cited by 1,012
Vaziri, H., & Benchimol, S. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70109-5 · Cited by 1,003 · cited 1×
“Evidence that it is causal was demonstrated by introducing the telomerase catalytic protein component [human telomerase reverse transcriptase (hTERT)] into normal human cells (18,19).”
BackgroundPaull, K. D., Shoemaker, R. H., Hodes, L., Monks, A., Scudiero, D. A., Rubinstein, L., Plowman, J., & Boyd, M. R. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.14.1088 · Cited by 967
Human telomeres contain two distinct Myb–related proteins, TRF1 and TRF2
Broccoli, D., Smogorzewska, A., Chong, L., & de Lange, T. (1997) · Nature Genetics · doi:10.1038/ng1097-231 · Cited by 926
Heterogeneity in telomere length of human chromosomes
Lansdorp, P. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.5.685 · Cited by 878
Structure and variability of human chromosome ends.
de Lange, T., Shiue, L., Myers, R. M., Cox, D. R., Naylor, S. L., Killery, A. M., & Varmus, H. E. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.2.518 · Cited by 848
Absence of cancer–associated changes in human fibroblasts immortalized with telomerase
Morales, C. P., Holt, S. E., Ouellette, M., Kaur, K. J., Yan, Y., Wilson, K. S., White, M. A., Wright, W. E., & Shay, J. W. (1999) · Nature Genetics · doi:10.1038/5063 · Cited by 803
Self-citationInhibition of Human Telomerase by a G-Quadruplex-Interactive Compound
Sun, D., Thompson, B., Cathers, B. E., Salazar, M., Kerwin, S. M., Trent, J. O., Jenkins, T. C., Neidle, S., & Hurley, L. H. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm970199z · Cited by 794
Control of Human Telomere Length by TRF1 and TRF2
Smogorzewska, A., van Steensel, B., Bianchi, A., Oelmann, S., Schaefer, M. R., Schnapp, G., & de Lange, T. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.5.1659-1668.2000 · Cited by 768
Telomere shortening and apoptosis in telomerase-inhibited human tumor cells
Zhang, X., Mar, V., Zhou, W., Harrington, L., & Robinson, M. O. (1999) · Genes & Development · doi:10.1101/gad.13.18.2388 · Cited by 698
Chong, L., van Steensel, B., Broccoli, D., Erdjument-Bromage, H., Hanish, J., Tempst, P., & de Lange, T. (1995) · Science · doi:10.1126/science.270.5242.1663 · Cited by 694
Jiang, X.-R., Jimenez, G., Chang, E., Frolkis, M., Kusler, B., Sage, M., Beeche, M., Bodnar, A. G., Wahl, G. M., Tlsty, T. D., et al. (1999) · Nature Genetics · doi:10.1038/5056 · Cited by 668
A Mammalian Telomerase-Associated Protein
Harrington, L., McPhail, T., Mar, V., Zhou, W., Oulton, R., Program, A. E., Bass, M. B., Arruda, I., & Robinson, M. O. (1997) · Science · doi:10.1126/science.275.5302.973 · Cited by 663
Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization
Counter, C. M., Hahn, W. C., Wei, W., Caddle, S. D., Beijersbergen, R. L., Lansdorp, P. M., Sedivy, J. M., & Weinberg, R. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14723 · Cited by 649
Correlating telomerase activity levels with human neuroblastoma outcomes
Hiyama, E., Hiyama, K., Yokoyama, T., Matsuura, Y., Piatyszek, M. A., & Shay, J. W. (1995) · Nature Medicine · doi:10.1038/nm0395-249 · Cited by 611
Self-citationCell-cycle-regulated association of RAD50/MRE11/NBS1 with TRF2 and human telomeres
Zhu, X.-D., Küster, B., Mann, M., Petrini, J. H. J., & Lange, T. D. (2000) · Nature Genetics · doi:10.1038/77139 · Cited by 606
Secondary Structure of Vertebrate Telomerase RNA
Chen, J.-L., Blasco, M. A., & Greider, C. W. (2000) · Cell · doi:10.1016/s0092-8674(00)80687-x · Cited by 605
Li, B., Oestreich, S., & de Lange, T. (2000) · Cell · doi:10.1016/s0092-8674(00)80858-2 · Cited by 583
Vonderheide, R. H., Hahn, W. C., Schultze, J. L., & Nadler, L. M. (1999) · Immunity · doi:10.1016/s1074-7613(00)80066-7 · Cited by 570
Herbert, B.-S., Pitts, A. E., Baker, S. I., Hamilton, S. E., Wright, W. E., Shay, J. W., & Corey, D. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.25.14276 · Cited by 539
Self-citationFunctional requirement of p23 and Hsp90 in telomerase complexes
Holt, S. E., Aisner, D. L., Baur, J., Tesmer, V. M., Dy, M., Ouellette, M., Trager, J. B., Morin, G. B., Toft, D. O., Shay, J. W., et al. (1999) · Genes & Development · doi:10.1101/gad.13.7.817 · Cited by 539
Self-citationTIN2, a new regulator of telomere length in human cells
Kim, S.-H., Kaminker, P., & Campisi, J. (1999) · Nature Genetics · doi:10.1038/70508 · Cited by 525 · cited 2×
“Human telomere proteinsa TRF1 (telomeric repeat binding factor 1: binds duplex TTAGGG) Tankyrase (TRF1 interacting protein: poly (ADP-ribose) polymerase) TIN2 (TRF1 interacting protein 2) TRF2 (telomeric repeat binding factor 2: binds duplex TTAGGG and end protection) hRap1 (TRF2 interacting protein: end protection) M…”
BackgroundA Box H/ACA Small Nucleolar RNA-Like Domain at the Human Telomerase RNA 3′ End
Mitchell, J. R., Cheng, J., & Collins, K. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.567 · Cited by 510
Telomeric localization of TRF2, a novel human telobox protein
Bilaud, T., Brun, C., Ancelin, K., Koering, C. E., Laroche, T., & Gilson, E. (1997) · Nature Genetics · doi:10.1038/ng1097-236 · Cited by 506
In vivo loss of telomeric repeats with age in humans
Lindsey, J., McGill, N. I., Lindsey, L. A., Green, D. K., & Cooke, H. J. (1991) · Mutation Research/DNAging · doi:10.1016/0921-8734(91)90032-7 · Cited by 463
The telomerase reverse transcriptase: components and regulation
Nugent, C. I., & Lundblad, V. (1998) · Genes & Development · doi:10.1101/gad.12.8.1073 · Cited by 438
Replicative Senescence: An Old Lives' Tale?
Campisi, J. (1996) · Cell · doi:10.1016/s0092-8674(00)81023-5 · Cited by 432
Telomerase Activity in Human Breast Tumors
Hiyama, E., Gollahon, L., Kataoka, T., Kuroi, K., Yokoyama, T., Gazdar, A. F., Hiyama, K., Piatyszek, M. A., & Shay, J. W. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.2.116 · Cited by 423
Self-citationTankyrase promotes telomere elongation in human cells
Smith, S., & de Lange, T. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00752-1 · Cited by 418
Human endothelial cell life extension by telomerase expression
Yang, J., Chang, E., Cherry, A. M., Bangs, C. D., Oei, Y., Bodnar, A., Bronstein, A., Chiu, C.-P., & Herron, G. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.37.26141 · Cited by 410
Wright, W. E., & Shay, J. W. (2000) · Nature Medicine · doi:10.1038/78592 · Cited by 398
Self-citationTelomerase activity in human cancer
Shay, J. W., & Wright, W. E. (1996) · Current Opinion in ONCOLOGY · doi:10.1097/00001622-199601000-00012 · Cited by 398
Self-citationTelomerase activity: a prevalent marker of malignant human prostate tissue.
Sommerfeld, H. J., Meeker, A. K., Piatyszek, M. A., Bova, G. S., Shay, J. W., & Coffey, D. S. (1996) · PubMed · Cited by 391
Self-citationPiatyszek, M. A., Kim, N. W., Weinrich, S. L., Hiyama, K., Hiyama, E., Wright, W. E., & Shay, J. W. (1995) · Methods in Cell Science · doi:10.1007/bf00981880 · Cited by 384
Self-citationThe two-stage mechanism controlling cellular senescence and immortalization
Wright, W. E., & Shay, J. W. (1992) · Experimental Gerontology · doi:10.1016/0531-5565(92)90069-c · Cited by 383
Self-citationDefining the molecular mechanisms of human cell immortalization
Shay, J. W., Wright, W. E., & Werbin, H. (1991) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(91)90003-4 · Cited by 383
Self-citationTelomerase extends the lifespan of virus-transformed human cells without net telomere lengthening
Zhu, J., Wang, H., Bishop, J. M., & Blackburn, E. H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3723 · Cited by 381
Inhibition of human telomerase activity by peptide nucleic acids
Norton, J. C., Piatyszek, M. A., Wright, W. E., Shay, J. W., & Corey, D. R. (1996) · Nature Biotechnology · doi:10.1038/nbt0596-615 · Cited by 343
Self-citationKu acts in a unique way at the mammalian telomere to prevent end joining
Hsu, H.-L., Gilley, D., Galande, S. A., Hande, M. P., Allen, B., Kim, S.-H., Li, G. C., Campisi, J., Kohwi-Shigematsu, T., & Chen, D. J. (2000) · Genes & Development · doi:10.1101/gad.844000 · Cited by 342
Telomerase prevents the accelerated cell ageing of Werner syndrome fibroblasts
Wyllie, F. S., Jones, C. J., Skinner, J. W., Haughton, M. F., Wallis, C., Wynford-Thomas, D., Faragher, R. G. A., & Kipling, D. (2000) · Nature Genetics · doi:10.1038/71630 · Cited by 332
THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS
HAYFLICK, L., & MOORHEAD, P. S. (1964) · Cytogenetics of Cells in Culture · doi:10.1016/b978-1-4832-3075-7.50017-7 · Cited by 307
Cellular senescence as a tumor-protection mechanism: the essential role of counting
Wright, W. E., & Shay, J. W. (2001) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(00)00163-5 · Cited by 306
Self-citationTelomerase and the maintenance of chromosome ends
Bryan, T. M., & Cech, T. R. (1999) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)80043-x · Cited by 301
LaBranche, H., Dupuis, S., Ben-David, Y., Bani, M.-R., Wellinger, R. J., & Chabot, B. (1998) · Nature Genetics · doi:10.1038/575 · Cited by 280
Telomere Shortening Is Proportional to the Size of the G-rich Telomeric 3′-Overhang
Huffman, K. E., Levene, S. D., Tesmer, V. M., Shay, J. W., & Wright, W. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002843200 · Cited by 273
Self-citationRole of telomerase in cellular proliferation and cancer
Holt, S. E., & Shay, J. W. (1999) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199907)180:1<10::aid-jcp2>3.0.co;2-d · Cited by 259
Self-citationMitchell, J. R., & Collins, K. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00036-8 · Cited by 258
Functions of poly(ADP-ribose) polymerase in controlling telomere length and chromosomal stability
Fagagna, F. D. D., Hande, M. P., Tong, W.-M., Lansdorp, P. M., Wang, Z.-Q., & Jackson, S. P. (1999) · Nature Genetics · doi:10.1038/12680 · Cited by 255
Cytotoxic T cell immunity against telomerase reverse transcriptase in humans
Minev, B., Hipp, J., Firat, H., Schmidt, J. D., Langlade-Demoyen, P., & Zanetti, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.070560797 · Cited by 255
Ishikawa, F., Matunis, M. J., Dreyfuss, G., & Cech, T. R. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.7.4301 · Cited by 250
2,7-Disubstituted Amidofluorenone Derivatives as Inhibitors of Human Telomerase
Perry, P. J., Read, M. A., Davies, R. T., Gowan, S. M., Reszka, A. P., Wood, A. A., Kelland, L. R., & Neidle, S. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm990084q · Cited by 226
Ouellette, M. M. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.3.403 · Cited by 219
Telomerase activity in human brain tumours
Langford, L. A., Piatyszek, M. A., Shay, J. W., & Schold, S. C. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91865-5 · Cited by 218
Self-citationTRF1 binds a bipartite telomeric site with extreme spatial flexibility
Bianchi, A., Stansel, R. M., Fairall, L., Griffith, J. D., Rhodes, D., & de Lange, T. (1999) · The EMBO Journal · doi:10.1093/emboj/18.20.5735 · Cited by 217
Pannone, B. K. (1998) · The EMBO Journal · doi:10.1093/emboj/17.24.7442 · Cited by 204
Smith, S., & de Lange, T. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.21.3649 · Cited by 202
Telomeres and senescence: The history, the experiment, the future
Greider, C. W. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70105-8 · Cited by 191
Kondo, S., Kondo, Y., Li, G., Silverman, R. H., & Cowell, J. K. (1998) · Oncogene · doi:10.1038/sj.onc.1201885 · Cited by 190
Telomerase Activity Is Sufficient To Allow Transformed Cells To Escape from Crisis
Halvorsen, T. L., Leibowitz, G., & Levine, F. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.1864 · Cited by 182
White, L. K., Wright, W. E., & Shay, J. W. (2001) · Trends in Biotechnology · doi:10.1016/s0167-7799(00)01541-9 · Cited by 171
Self-citationCellular delivery of peptide nucleic acids and inhibition of human telomerase
Hamilton, S. E., Simmons, C. G., Kathiriya, I. S., & Corey, D. R. (1999) · Chemistry & Biology · doi:10.1016/s1074-5521(99)80046-5 · Cited by 170
Antisense oligonucleotides as therapeutic agents
Galderisi, U., Cascino, A., & Giordano, A. (1999) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199911)181:2<251::aid-jcp7>3.0.co;2-d · Cited by 167
Dragon, F., Pogačić, V., & Filipowicz, W. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.9.3037-3048.2000 · Cited by 166
Vaults and Telomerase Share a Common Subunit, TEP1
Kickhoefer, V. A., Stephen, A. G., Harrington, L., Robinson, M. O., & Rome, L. H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.46.32712 · Cited by 164
Hiyama, E., Hiyama, K., Yokoyama, T., & Shay, J. W. (2001) · Neoplasia · doi:10.1038/sj.neo.7900134 · Cited by 162
Self-citationHuman telomerase inhibition by substituted acridine derivatives
Harrison, R. J., Gowan, S. M., Kelland, L. R., & Neidle, S. (1999) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(99)00394-7 · Cited by 161
Identification of Two RNA-binding Proteins Associated with Human Telomerase RNA
Le, S., Sternglanz, R., & Greider, C. W. (2000) · Molecular Biology of the Cell · doi:10.1091/mbc.11.3.999 · Cited by 161
Blackburn, E. H. (2000) · Nature Structural Biology · doi:10.1038/79594 · Cited by 160
Telomerase in the early detection of cancer.
Shay, J. W., & Gazdar, A. F. (1997) · Journal of Clinical Pathology · doi:10.1136/jcp.50.2.106 · Cited by 160
Self-citationRead, M. A., Wood, A. A., Harrison, J. R., Gowan, S. M., Kèlland, L. R., Dosanjh, H. S., & Neidle, S. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm990287e · Cited by 155
Naasani, I., Seimiya, H., Yamori, T., & TSURUO, T. (1999) · PubMed · Cited by 155
Telomerase RNA Bound by Protein Motifs Specific to Telomerase Reverse Transcriptase
Bryan, T. M., Goodrich, K. J., & Cech, T. R. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00048-4 · Cited by 153
Tesmer, V. M., Ford, L. P., Holt, S. E., Frank, B. C., Yi, X., Aisner, D. L., Ouellette, M. M., Shay, J. W., & Wright, W. E. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.9.6207 · Cited by 152
Self-citationKu Binds Telomeric DNA in Vitro
Bianchi, A., & de Lange, T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.30.21223 · Cited by 147
Kufel, J., Allmang, C., Chanfreau, G., Petfalski, E., Lafontaine, D. L. J., & Tollervey, D. W. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.15.5415-5424.2000 · Cited by 137
Telomerase inhibition by peptide nucleic acids reverses `immortality' of transformed human cells
Shammas, M. A., Simmons, C. G., Corey, D. R., & Shmookler Reis, R. J. (1999) · Oncogene · doi:10.1038/sj.onc.1203069 · Cited by 135
Nucleolar localization signals of Box H/ACA small nucleolar RNAs
Narayanan, A., Lukowiak, A., Jády, B. E., Dragon, F., Kiss, T., Terns, R. M., & Terns, M. P. (1999) · The EMBO Journal · doi:10.1093/emboj/18.18.5120 · Cited by 133
The reactivation of telomerase activity in cancer progression
Shay, J. W., & Wright, W. E. (1996) · Trends in Genetics · doi:10.1016/0168-9525(96)30018-8 · Cited by 132
Self-citationTatsumoto, N., Hiyama, E., Murakami, Y., Imamura, Y., Shay, J. W., Matsuura, Y., & Yokoyama, T. (2000) · PubMed · Cited by 132
Self-citationHolt, S. E., Norton, J. C., Wright, W. E., & Shay, J. W. (1996) · Methods in Cell Science · doi:10.1007/bf00132889 · Cited by 131
Self-citationhnRNP A2/B1 binds specifically to single stranded vertebrate telomeric repeat TTAGGGn
McKay, S. J., & Cooke, H. J. (1992) · Nucleic Acids Research · doi:10.1093/nar/20.24.6461 · Cited by 131
Thomas, M., Yang, L., & Hornsby, P. J. (2000) · Nature Biotechnology · doi:10.1038/71894 · Cited by 129
Melana, S. M., Holland, J. F., & Pogo, B. G. T. (1998) · PubMed · Cited by 122
For Better or Worse? Telomerase Inhibition and Cancer
de Lange, T., & Jacks, T. (1999) · Cell · doi:10.1016/s0092-8674(00)81955-8 · Cited by 119
Gilley, D. P., & Blackburn, E. H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6621 · Cited by 117
Aging and cancer: are telomeres and telomerase the connection?
Shay, J. W. (1995) · Molecular Medicine Today · doi:10.1016/s1357-4310(95)93872-9 · Cited by 116
Self-citationMorales, C. P., Lee, E. L., & Shay, J. W. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980815)83:4<652::aid-cncr4>3.0.co;2-m · Cited by 116
Self-citationYokoyama, Y., Takahashi, Y., Shinohara, A., Lian, Z., Wan, X., Niwa, K., & Tamaya, T. (1998) · PubMed · Cited by 107
Eversole, A., & Maizels, N. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.15.5425-5432.2000 · Cited by 102
Ohyashiki, K., Ohyashiki, J. H., Nishimaki, J., Toyama, K., Ebihara, Y., Kato, H., Wright, W. E., & Shay, J. W. (1997) · PubMed · Cited by 98
Self-citationTreatment of prostate cancer in vitro and in vivo with 2-5A-anti-telomerase RNA component
Kondo, Y., Koga, S., Komata, T., & Kondo, S. (2000) · Oncogene · doi:10.1038/sj.onc.1203538 · Cited by 98
Influence of ATM function on telomere metabolism
Smilenov, L. B., Morgan, S. E., Sawant, S. G., Kastan, M. B., & Pandita, T. K. (1997) · Oncogene · doi:10.1038/sj.onc.1201449 · Cited by 92
Wood, L. D., Halvorsen, T. L., Dhar, S., Baur, J. A., Pandita, R. K., Wright, W. E., Hande, M. P., Calaf, G., Hei, T. K., Levine, F., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1204072 · Cited by 91
Self-citationTelomerase activity in human renal cell carcinoma.
Mehle, C., Piatyszek, M. A., Ljungberg, B., Shay, J. W., & Roos, G. (1996) · PubMed · Cited by 90
Self-citationDallaire, F., Dupuis, S., Fiset, S., & Chabot, B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.19.14509 · Cited by 87
Clinical implications of telomerase activity levels in acute leukemia.
Ohyashiki, J. H., Ohyashiki, K., Iwama, H., Hayashi, S., Toyama, K., & Shay, J. W. (1997) · PubMed · Cited by 87
Self-citationThe use of telomerized cells for tissue engineering
Shay, J. W., & Wright, W. E. (2000) · Nature Biotechnology · doi:10.1038/71872 · Cited by 85
Self-citation2-5A Antisense Directed against Telomerase RNA Produces Apoptosis in Ovarian Cancer Cells
Kushner, D. M., Paranjape, J. M., Bandyopadhyay, B., Cramer, H., Leaman, D. W., KENNEDY, A. W., Silverman, R. H., & Cowell, J. K. (2000) · Gynecologic Oncology · doi:10.1006/gyno.1999.5668 · Cited by 82
Irreversible Telomere Shortening by 3′-Azido-2′, 3′-Dideoxythymidine (AZT) Treatment
Gomez, D. E., Tejera, Á. M., & Olivero, O. A. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8555 · Cited by 82
Folini, M., Colella, G., Villa, R., Lualdi, S., Daidone, M. G., & Zaffaroni, N. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00870.x · Cited by 80
Mata, J. E., Joshi, S. S., Palen, B. N., Pirruccello, S. J., Jackson, J. D., Elias, N., Page, T. J., Medlin, K. L., & Iversen, P. L. (1997) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1997.8103 · Cited by 76
Murakami, J., Nagai, N., Shigemasa, K., & Ohama, K. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00037-4 · Cited by 68
Telomerase activity and expression of its RNA component in cervical lesions
Yashima, K., Ashfaq, R., Nowak, J. A., von Gruenigen, V., Milchgrub, S., Rathi, A., Albores‐Saavedra, J., Shay, J. W., & Gazdar, A. F. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980401)82:7<1319::aid-cncr15>3.0.co;2-9 · Cited by 64
Self-citationFord, L. P., Shay, J. W., & Wright, W. E. (2001) · RNA · doi:10.1017/s1355838201010159 · Cited by 58
Self-citationAtypical glandular cells of undetermined significance
Soofer, S. B., & Sidawy, M. K. (2000) · Cancer · doi:10.1002/1097-0142(20000825)90:4<235::aid-cncr6>3.0.co;2-z · Cited by 57
Decline in telomerase activity as a measure of tumor cell killing by antineoplastic agents in vitro.
Faraoni, I., Turriziani, M., Masci, G., Vecchis, L. D., Shay, J. W., Bonmassar, E., & Graziani, G. (1997) · PubMed · Cited by 57
Self-citationTelomerase and Early Detection of Cancer: a National Cancer Institute Workshop
Breslow, R. A., Shay, J. W., Gazdar, A. F., & Srivastava, S. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.9.618 · Cited by 52
Self-citationApplications of telomerase research in the fight against cancer
McKenzie, K. E., Umbricht, C. B., & Sukumar, S. V. (1999) · Molecular Medicine Today · doi:10.1016/s1357-4310(98)01429-4 · Cited by 51
Progressive Increase in Telomerase Activity From Benign Melanocytic Conditions to Malignant Melanoma
Ramirez, R. D., D’Atri, S., Pagani, E., Faraggiana, T., Lacal, P. M., Taylor, R. S., & Shay, J. W. (1999) · Neoplasia · doi:10.1038/sj.neo.7900004 · Cited by 49
Self-citationTelomerase in cancer: diagnostic, prognostic, and therapeutic implications.
Shay, J. W. (1998) · PubMed · Cited by 47
Self-citationAt the end of the millennium, a view of the end
Shay, J. W. (1999) · Nature Genetics · doi:10.1038/70480 · Cited by 45
Self-citationToward Identifying a Cellular Determinant of Telomerase Repression
Shay, J. W. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.1.4 · Cited by 42
Self-citationMutant Dyskerin Ends Relationship with Telomerase
Shay, J. W., & Wright, W. E. (1999) · Science · doi:10.1126/science.286.5448.2284 · Cited by 38
Self-citationJohnston, S. D., Lew-Smith, J., & Berman, J. G. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.923 · Cited by 31
Telomerase: An Unusual Target for Cytotoxic Agents
Corey, D. R. (2000) · Chemical Research in Toxicology · doi:10.1021/tx0000872 · Cited by 20
Telomerase Activity in Human Brain Tumors
Harada, K., Kurisu, K., Sugiyama, K., Sadatomo, T., Tahara, H., & Ide, T. (1996) · Tissue culture research communications : the journal of experimental & applied cell culture research · Cited by 7
Ku binds telomeric DNA in vitro.
Bianchi, A., & de Lange, T. (1999) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)53460-3 · Cited by 6
Telomerase activity in human germline and embryonic tissues and cells
Wright, W. E., Piatyszek, M. A., Rainey, W. E., Byrd, W., & Shay, J. W. (1996) · Developmental Genetics · doi:10.1002/(sici)1520-6408(1996)18:2<173::aid-dvg10>3.0.co;2-3
Self-citation
Cited by
Mechanisms of DNA damage, repair, and mutagenesis
Chatterjee, N., & Walker, G. C. (2017) · Environmental and Molecular Mutagenesis · doi:10.1002/em.22087 · Cited by 2,039
Rules for Making Human Tumor Cells
Hahn, W. C., & Weinberg, R. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmra021902 · Cited by 951
Leiserson, M. D. M., Vandin, F., Wu, H.-T., Dobson, J. R., Eldridge, J. V., Thomas, J. L., Papoutsaki, A., Kim, Y., Niu, B., McLellan, M., et al. (2015) · Nature Genetics · doi:10.1038/ng.3168 · Cited by 903
Turinetto, V., Vitale, E., & Giachino, C. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17071164 · Cited by 486
The association of telomere length and cancer: a meta-analysis
Wentzensen, I. M., Mirabello, L., Pfeiffer, R. M., & Savage, S. A. (2011) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0005 · Cited by 458
Metadata
- Authors
- Shay, J. W.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-04-01
- Volume
- 10
- Issue
- 7
- Pages
- 677-685
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2110752622
- Cited by
- 509
- References
- 145
- FWCI
- 15.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.